|
End-of-day quote
Korea S.E.
2026-09-11
|
5-day change | 1st Jan Change | ||
| 3,250.00 KRW | -1.52% |
|
-5.39% | -52.76% |
| 04-13 | Genome & Company announced that it has received KRW 6.99999414 billion in funding | CI |
| 04-02 | Genome & Company announced that it expects to receive KRW 6.99999414 billion in funding | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.52% | -5.39% | -27.13% | -39.81% | -52.76% | +15.45% | -58.39% | -86.10% | - | 127M | |
| +1.66% | -3.60% | -3.95% | +9.17% | +0.48% | -1.24% | +10.44% | -30.41% | +196.60% | 45.48B | |
| +0.21% | -2.98% | +0.88% | +32.43% | +155.83% | +337.74% | +520.30% | +588.88% | - | 43.68B | |
| +1.74% | -2.24% | +8.38% | +44.26% | +16.13% | +39.82% | +20.85% | +2.43% | +237.64% | 43.09B | |
| +1.38% | -3.28% | -2.67% | +31.02% | +14.05% | +6.84% | +73.19% | -4.87% | +994.13% | 39.4B | |
| -1.44% | -5.26% | -11.78% | +3.01% | +3.38% | +8.97% | +39.76% | -17.27% | +134.37% | 31.91B | |
| +0.87% | -2.60% | +7.02% | +20.85% | - | - | - | - | - | 17.31B | |
| +0.75% | -0.64% | +0.96% | +25.72% | +4.61% | +19.75% | +108.58% | +216.50% | +1,870.22% | 16.4B | |
| +2.77% | +1.48% | +3.15% | +14.64% | +16.44% | +15.19% | +31.82% | -41.12% | +94.12% | 14.24B | |
| +1.93% | -3.55% | -1.07% | +48.40% | +39.49% | +82.00% | +36.66% | -35.47% | +249.49% | 13.28B | |
| +2.18% | +2.71% | +1.09% | +15.82% | -7.08% | -3.25% | -36.13% | -34.06% | +123.16% | 13.06B | |
| +0.06% | -0.43% | -0.07% | +33.56% | +22.63% | +40.69% | -0.51% | -42.60% | +173.23% | 11.31B | |
| +0.46% | -8.68% | +8.69% | +23.40% | -0.07% | -31.69% | - | - | - | 10.65B | |
| -0.69% | +2.81% | -1.95% | +18.33% | -16.36% | +40.45% | +511.04% | +208.42% | +1,277.56% | 10.25B | |
| -3.06% | -2.21% | -19.12% | +79.98% | +41.68% | +19.35% | +48.03% | -52.92% | - | 10.13B | |
| +2.08% | +1.69% | -2.14% | +34.98% | +69.66% | +151.75% | +703.58% | +226.46% | +1,050.47% | 9.59B | |
| -1.74% | -2.07% | +0.47% | +33.36% | +47.74% | +144.65% | +491.97% | +81.18% | - | 9.56B | |
| -1.18% | -4.90% | -9.20% | +25.51% | +13.52% | +787.36% | +1,589.80% | +7.65% | - | 9.34B | |
| +5.07% | +9.68% | +36.66% | +188.14% | +173.75% | +99.41% | +80.28% | +2.26% | +1,260.00% | 9.02B | |
| -2.59% | -6.68% | -2.97% | -26.02% | -31.48% | -14.17% | +25.63% | +49.46% | +84.26% | 9.01B | |
| Average | +0.40% | -2.43% | -0.74% | +30.84% | +26.93% | +92.58% | +233.16% | +57.69% | +595.79% | 18.34B | |
| Weighted average by Cap. | +0.71% | -2.88% | -0.01% | +29.65% | +34.23% | +86.55% | +187.28% | +89.53% | +514.29% |
- Stock Market
- Stocks
- A314130 Stock
- Sector Genome & Company
Select your edition
All financial news and data tailored to specific country editions
